): 494496.
[18] Grob D, Simpson D, Mitsumoto H, et al. Treatment of myasthenia gravis by immunoadsorption of plasma[J]. Neurology, 1995, 45(2): 338344.
[19] 杨明山. 血液疗法在神经免疫性疾病中的应用[J]. 卒中与神经疾病, 1997, 4(3): 155.
[20] Schulenburg A, Haas M, Goldammer A, et al. Autologous stem cell transplantation for refractory myasthenia gravis[J]. Bone Marrow Trans plantation, 2002, 29: 472a.
[21] Ahlberg R, Yi Q, Pirskanen R, et al. Treatment of myasthenia gravis with antiCD4 antibody[J]. Neurology, 1994, 44 (9): 1762.
[22] 臧敬五, 秦莹. T细胞接种在自身免疫性疾病中的临床应用[J]. 上海免疫杂志，1997, 17(2): 68.
[23] Burtin. Theoritical mechanism by which immunoglobulin theray might benefit myasthenia graviis[J]. Clin Immunol Immunopathol, 1989, 53: 83.
[24] Gajdos P, Chevret S, Toyka K. Intravenous immunoglobulin for myasthenia gravis[J]. Cochrane Database Syst Rev,2008, 23 (1): CD002277.
[25] Chavis PS, Stickler DE, Walker A. Immunosuppressive or surgical treatment for ocular Myasthenia Gravis[J].Arch Neurol,2007,64(12): 17921794.
[26] Scotta BG, Yang H, Tuzun E, et al. ICOS is essential for the development of experimental autoimmune[J]. Neuroimmunol, 2004, 153 (1/2): 1625.
仁和医学论文网专业提供代写代发医学论文服务，并提供大量论文资料，如有业务需求请咨询网站客服人员！
上一页 [1] [2] [3] [4]
您现在的位置： 绿色健康网 >> 医学论文 >> 临床医学论文 >> 正文